Disc Medicine (Disc) has secured a $200m non-dilutive term loan facility from Hercules Capital to advance the clinical trials of assets across its portfolio.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,